Veronique Lisi

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Systematic analysis of RhoGAP expression and function in border cell morphology and migration.

Systematic analysis of RhoGAP expression and function in border cell morphology and migration.

Journal: bioRxiv : the preprint server for biology
Published: April 17, 2026

Concurrent SF3B1 Mutation and BCR::ABL1 Demonstrating a Myelodysplastic Syndrome Phenotype: A Case Report.

Concurrent SF3B1 Mutation and BCR::ABL1 Demonstrating a Myelodysplastic Syndrome Phenotype: A Case Report.

Journal: EJHaem
Published: January 25, 2026

Modeling KRAS mutations in KMT2A::MLLT3 acute myeloid leukemia promotes leukemic progression and transcriptional rewiring.

Modeling KRAS mutations in KMT2A::MLLT3 acute myeloid leukemia promotes leukemic progression and transcriptional rewiring.

Journal: Leukemia
Published: July 21, 2025

Ubiquitous dysregulation of the Wnt pathway in immune thrombocytopenia genetic susceptibility.

Ubiquitous dysregulation of the Wnt pathway in immune thrombocytopenia genetic susceptibility.

Journal: Blood vessels, thrombosis & hemostasis
Published: May 20, 2025

High IL1R1 expression predicts poor survival and benefit from stem cell transplant in intermediate-risk acute myeloid leukemia from the Leucegene cohort.

High IL1R1 expression predicts poor survival and benefit from stem cell transplant in intermediate-risk acute myeloid leukemia from the Leucegene cohort.

Journal: Biomarker research
Published: May 15, 2025

Surface CD81 supports leukemia stem cell function and reveals a therapeutic vulnerability in acute myeloid leukemia.

Surface CD81 supports leukemia stem cell function and reveals a therapeutic vulnerability in acute myeloid leukemia.

Journal: Signal transduction and targeted therapy
Published: April 02, 2025

IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia.

IL1RAP is an immunotherapeutic target for normal karyotype triple-mutated acute myeloid leukemia.

Journal: Biomarker research
Published: November 06, 2024

Replication of a GWAS signal near HLA-DQA2 with AML using a disease-only cohort and external population-based controls.

Replication of a GWAS signal near HLA-DQA2 with AML using a disease-only cohort and external population-based controls.

Journal: Blood neoplasia
Published: September 30, 2024

Therapeutic Inducers of Natural Killer cell Killing (ThINKK): preclinical assessment of safety and efficacy in allogeneic hematopoietic stem cell transplant settings.

Therapeutic Inducers of Natural Killer cell Killing (ThINKK): preclinical assessment of safety and efficacy in allogeneic hematopoietic stem cell transplant settings.

Journal: Journal for immunotherapy of cancer
Published: April 28, 2024

Induced Pluripotent Stem Cell-Derived Fibroblasts Efficiently Engage Senescence Pathways but Show Increased Sensitivity to Stress Inducers.

Induced Pluripotent Stem Cell-Derived Fibroblasts Efficiently Engage Senescence Pathways but Show Increased Sensitivity to Stress Inducers.

Journal: Cells
Published: April 24, 2024

Immunotherapeutic targeting of surfaceome heterogeneity in AML.

Immunotherapeutic targeting of surfaceome heterogeneity in AML.

Journal: Cell reports
Published: October 05, 2023

Senescence drives immunotherapy resistance by inducing an immunosuppressive tumor microenvironment.

Senescence drives immunotherapy resistance by inducing an immunosuppressive tumor microenvironment.

Journal: Nature communications
Published: July 20, 2023
Showing 1-12 of 26

Last Updated: 09/26/2026